beta-Alanine elevates dopamine levels in the rat nucleus accumbens: antagonism by strychnine. 2010

Mia Ericson, and Rhona B C Clarke, and PeiPei Chau, and Louise Adermark, and Bo Söderpalm
Addiction Biology Unit, Section of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, PO Box 410, 405 30, Göteborg, Sweden. mia.ericson@neuro.gu.se

Glycine receptors (GlyRs) in the nucleus accumbens (nAc) have recently been suggested to be involved in the reinforcing and dopamine-elevating properties of ethanol via a neuronal circuitry involving the VTA. Apart from ethanol, both glycine and taurine have the ability to modulate dopamine output via GlyRs in the same brain region. In the present study, we wanted to explore whether yet another endogenous ligand for the GlyR, beta-alanine, had similar effects. To this end, we monitored dopamine in the nAc by means of in vivo microdialysis and found that local perfusion of beta-alanine increased dopamine output. In line with previous observations investigating ethanol, glycine and taurine, the competitive GlyR antagonist strychnine completely blocked the dopamine elevation. The present results suggest that beta-alanine has the ability to modulate dopamine levels in the nAc via strychnine-sensitive GlyRs, and are consistent with previous studies suggesting the importance of this receptor for modulating dopamine output.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008297 Male Males
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013331 Strychnine An alkaloid found in the seeds of STRYCHNOS NUX-VOMICA. It is a competitive antagonist at glycine receptors and thus a convulsant. It has been used as an analeptic, in the treatment of nonketotic hyperglycinemia and sleep apnea, and as a rat poison. Strychnine Nitrate,Nitrate, Strychnine
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Mia Ericson, and Rhona B C Clarke, and PeiPei Chau, and Louise Adermark, and Bo Söderpalm
June 2006, The European journal of neuroscience,
Mia Ericson, and Rhona B C Clarke, and PeiPei Chau, and Louise Adermark, and Bo Söderpalm
December 1998, European journal of pharmacology,
Mia Ericson, and Rhona B C Clarke, and PeiPei Chau, and Louise Adermark, and Bo Söderpalm
October 2001, Brain research,
Mia Ericson, and Rhona B C Clarke, and PeiPei Chau, and Louise Adermark, and Bo Söderpalm
December 2000, The European journal of neuroscience,
Mia Ericson, and Rhona B C Clarke, and PeiPei Chau, and Louise Adermark, and Bo Söderpalm
December 1997, Neuroreport,
Mia Ericson, and Rhona B C Clarke, and PeiPei Chau, and Louise Adermark, and Bo Söderpalm
May 1992, Neurochemical research,
Mia Ericson, and Rhona B C Clarke, and PeiPei Chau, and Louise Adermark, and Bo Söderpalm
April 2008, Psychopharmacology,
Mia Ericson, and Rhona B C Clarke, and PeiPei Chau, and Louise Adermark, and Bo Söderpalm
January 1995, Progress in neuro-psychopharmacology & biological psychiatry,
Mia Ericson, and Rhona B C Clarke, and PeiPei Chau, and Louise Adermark, and Bo Söderpalm
January 1992, Psychopharmacology,
Mia Ericson, and Rhona B C Clarke, and PeiPei Chau, and Louise Adermark, and Bo Söderpalm
November 1987, Journal of neurochemistry,
Copied contents to your clipboard!